JP Morgan Maintains Overweight on Rallybio, Raises Price Target to $18
Portfolio Pulse from richadhand@benzinga.com
JP Morgan analyst Anupam Rama maintains an Overweight rating on Rallybio (NASDAQ:RLYB) and raises the price target from $17 to $18.
August 10, 2023 | 4:42 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
JP Morgan maintains an Overweight rating on Rallybio and raises the price target from $17 to $18, indicating a positive outlook for the stock.
The raised price target by JP Morgan indicates a positive outlook for Rallybio. This could lead to increased investor confidence and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100